5982 Macromolecules, Vol. 43, No. 14, 2010
Scheme 1. General Strategy To Prepare AB2 Supramolecular Miktoarm Stars
Chen et al.
Characterization Methods. 1H and 13C NMR spectra were
recorded on a Bruker AVANCE250 (250 MHz) or AVANCE400
(400 MHz) spectrometer using CDCl3 or CD2Cl2. ESI-MS spectra
(m/z) were measured on a Thermo-Finnigan Mat 95XL. Thymine-
functionalized PVAc, PMMA, and PI and 2,6-diacyldiamino-
pyridine-functionalized PS were analyzed with an apparatus run-
dissolved in anhydrous THF and warmed for 24 h at 80 °C. Ice
water was then added to the solution before extracting the
organic products with diethyl ether three times. The combined
organic extracts were rinsed with water and dried over MgSO4.
After solvent removal, column chromatography was undertaken
(ethyl acetate/cyclohexane, 1/1, v/v) to afford CTA2 as a red solid
in moderate yield (0.91 g, 52%). ESI-MS Calcd for (C31H38N2-
O4S2þNa)þ, 589.8; found, 589.3 m/z. 1H NMR (CDCl3; [CTA2]=
ning in THF at 25 °C (flow rate: 1 mL min-1) and equipped with a
3
Viscotek VE 1121 automatic injector, three Waters HR5E columns,
and a differential refractive index detector (Viscotek VE3580). The
average molar masses of PVAc, PS, PI, and PMMA were derived
from a calibration curve based on PS and PMMA standards res-
pectively. In the case of PVAc samples, the obtained molar masses
were subsequently corrected using the Mark-Houwink-Sakurada
(MHS) relationship between PS and PVAc with MHS parameters
at 25 °C: KPS = 14.1 ꢀ 10-5 dL g-1, RPS = 0.70; KPVAc =16 ꢀ
10-5 dL g-1, and RPVAc =0.70. All MALDI-TOF mass spectra
were obtained with a Voyager-DE PRO (Applied Biosystems,
Framingham, MA) equipped with a nitrogen laser emitting at
337 nm with a 3 ns pulse duration. The instrument was operated in
reflector mode. The ions were accelerated under a potential of
20 kV. The positive ions were detected in all cases. The spectra were
the sum of 300 shots and an external mass calibration of mass
analyzer was used (a mixture of peptides, Sequazyme, Applied
Biosystems, Framingham, MA). Samples were prepared by mixing
45 or 20 μL of 1,8,9-anthracenetriol (dithranol, purchased by
1.68 ꢀ 10-2 mol L-1;δ(ppm)):1.26-1.65 (undecane CH2 groups,
3
18H), 1.91 (3H, s), 3.66 (2H, t), 4.13 (2H, t), 5.74 (1H, s) 6.97 (1H,
s), 7.30-7.41 (6H, m), 7.46-7.48 (2H, d), 7.77-7.83 (2H, d), 8.20
(1H, s). 13C NMR (CDCl3; δ (ppm)): 12.29, 25.72, 26.41, 26.93,
28.42, 29.16, 29.36, 29.64, 30.87, 40.78, 48.49, 58.97, 66.27, 110.38,
125.70, 125.79, 125.86, 125.90, 126.01, 128.41, 128.80, 129.01,
132.81, 133.46, 135.89, 140.51, 143.89, 151.23, 164.91, 168.83,
225.82.
Synthesis of CTA3. 2-Dodecylsulfanylthiocarbonylsulfanyl-
2-methyl-propionic acid (1.0 g, 2.7 mmol, 1.0 equiv) was dis-
solved in dry freshly distilled dichloromethane (50 mL) in a
round-bottom flask. The solution was cooled to 0 °C. Oxalyl
chloride (1.03 g, 8.1 mmol, 3 equiv) was added slowly under a
nitrogen atmosphere. The solution was allowed to reach room
temperature and stirred for a total of 3 h. The resulting solution
was concentrated under reduced pressure to yield the acid
chloride 3 (1.0 g, 99% yield). Compound 1 (0.7 g, 2.36 mmol)
was then dissolved in dry dichloromethane (40 mL) in a 100 mL
round-bottom flask and the solution was cooled to 0 °C. A solu-
tion of triethylamine (0.73 mL) in dichloromethane (5 mL) was
added dropwise over 10 min. A solution of 3 (1.0 g, 2.6 mmol) in
dichloromethane (5 mL) was added dropwise, and the solution
was allowed to reach room temperature while stirring for 3 h.
The solution was diluted with dichloromethane (100 mL) and
washed with saturated aqueous sodium bicarbonate solution
(50 mL), brine (50 mL), and water (50 mL), successively. The
organic layer was separated, dried over MgSO4, and filtered.
The supernatant was concentrated under reduced pressure. The
thymine-functionalized trithiocarbonate CTA3 was purified by
chromatography on silica gel (the separation was started with
methylene chloride/ethyl acetate 98/2, v/v and progressively
ethyl acetate was incorporated to reach 7/3, v/v). A yellow paste
was obtained (0.44 g, 29% yield). ESI-MS Calcd for (C33H58-
N2O3S3 þ K)þ, 666.1; found, 665.2 m/z. 1H NMR (CDCl3;
Sigma-Aldrich) at 10 g L-1 in THF, with 5 or 20 μL of PVAc or
3
PS solution (at 10 g L-1 in THF), respectively. To enhance
3
cationization of polymers, 5 μL of AgTFA or NaI (both from
Sigma-Aldrich, at 10 g L-1 in THF or acetone, respectively) were
3
added to solutions. Finally, resulting mixtures (0.5 μL) were
spotted on the MALDI sample plate and air-dried. TEM analyses
were performed on a Philips CM120 Transmission electron micro-
scope with an accelerating voltage of 80 kV, at the Centre Techno-
logique des Microstructures of the University of Lyon. The samples
were prepared from diluted polymer solutions (0.5 g L-1 in THF)
3
deposited onto carbon-coated Formvar copper grids. The solvent
was evaporated at room temperature. The grids were subsequently
exposed to RuO4 vapors (2 wt % of Ruthenium III chloride in
50/50 water/sodium hypochlorite solution) for 20 min (to stain the
PS domains).
Synthesis of CTA2. CTA2 was synthesized in three steps from
thymine. 1-(ω-Hydroxyundecyl)thymine (1, 1.05 g, 89%) was
first prepared as previously reported from 11-bromo-1-undecanol
(1.0 g, 3.98 mmol) and thymine (10.0 g, 79.3 mmol).13 To a
solution of 1 (1 g, 3.36 mmol) and pyridine (1.7 g, 21.5 mmol) in
anhydrous THF (150 mL), an excess of 2-chloro-2-phenylacetyl
chloride (2.0 g, 10.5 mmol) was added dropwise. The solution
was stirred for one day at 60 °C. After solvent removal, the
resulting brown oil was dissolved in ethyl acetate and succes-
sively washed with brine, saturated sodium bicarbonate, and a
0.1 M HCl solution. The organic layer was subsequently dried
over MgSO4, and the product was purified by silica gel (Kiesigel-
60) column chromatography (ethyl acetate/cyclohexane, 1/1, v/
v) to give the benzyl halide 2 as a yellow solid (1.20 g, 80%).
Compound 2 (1.2 g, 2.7 mmol) and freshly synthesized phenyl-
dithiocarboxylic acid magnesium bromide (60 mmol) were
[CTA3] = 1.68 ꢀ 10-2 mol L-1; δ (ppm)): 0.86 (t, 3H, CH3-
3
C9H18-CH2-CH2-S-CdS), 1.23-1.80 (m, 36H, CH3-C9H18-
CH2-CH2S-CdS and N-CH2-C9H18-CH2-O), 1.71 (s, 6H, -S-
C(CH3)2-CO, 1.90 (s, 3H, CH3-CdCH), 3.22 (t, 2H, CH3-
C9H18-CH2-CH2-S-CdS), 3.64 (t, 2H, N-CH2-C9H18-CH2-O),
4.04 (t, 2H, N-CH2-C9H18-CH2-O), 6.97 (s, 1H, CH3-CdCH-),
8.28 (s, 1H, NH). 13C NMR (CDCl3) δ (ppm): 12.63, 14.42,
22.97, 25.68, 26.18, 26.74, 27.20, 28.18, 28.64, 29.23, 29.40, 29.45,
29.49, 29.63, 29.71, 29.74, 29.85, 29.92, 32.20 37.15, 48.88, 56.32,
66.41, 110.81, 140.77, 151.21, 164.72, 173.32, 221.66.
Synthesis of CTA4. N,N0-2,6-Pyridinediylbis(2-bromopropan-
amide) 4 was prepared as previously reported.3 Freshly synthe-
sized dithiobenzoic acid (20.3 g, 130 mmol) and 4 (5 g, 13 mmol)
were dissolved in THF (300 mL) and stirred at 60 °C for 15 h.